deltatrials
Recruiting OBSERVATIONAL NCT05297331

Renal Stone Treatment Global Registry

A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Urinary Calculi - International Registry

Sponsor: Chinese University of Hong Kong

Conditions Urolithiasis
Updated 7 times since 2022 Last updated: Mar 26, 2025 Started: Mar 1, 2022 Primary completion: Dec 31, 2032 Completion: Mar 31, 2033
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Urolithiasis and is currently actively recruiting participants. Chinese University of Hong Kong leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Jul 2023 · 12 months · monthly snapshotRecruiting~Jul 2023 – ~Feb 2024 · 7 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotRecruiting~May 2025 – present · 14 months · monthly snapshotRecruiting

Change History

7 versions recorded

  1. May 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — May 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting

  5. Jul 2023 — Feb 2024 [monthly]

    Recruiting

▶ Show 2 earlier versions

  1. Jul 2022 — Jul 2023 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  2. Apr 2022 — Jul 2022 [monthly]

    Not Yet Recruiting

    First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese University of Hong Kong
Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations